In global research trials, a new drug called Baxdrostat has lowered blood pressure by an average of 9-10 mmHg, dramatically cutting the risk of heart attacks and strokes.

Baxdrostat is an investigational aldosterone synthase inhibitor developed by AstraZeneca for patients with uncontrolled or resistant hypertension. The company plans to file for regulatory approval by the end of 2025, with potential approvals expected in the U.S. and EU in 2026.

Heart attacks and strokes are the leading causes of death in some countries, and their likelihood is directly related to blood pressure. Lower the latter, and the former will be lowered too. A drug like this has the potential to have a big effect on increasing the average human lifespan around the world. If you add in the effects of new drugs like Ozempic on obesity, we may be about to see huge reductions in heart disease.

https://scitechdaily.com/new-pill-dramatically-lowers-dangerous-high-blood-pressure/